FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Professur für Tumorimmunologie (Schwerpunkt Systembiologie)
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Department of Dermatology
Lehrstuhl für Haut- und Geschlechtskrankheiten
Overview
Publications
(123)
Research Grants
(16)
Research Fields
(2)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity (2024)
Wang Y, Ertl C, Schmitt C, Hammann L, Kramer R, Grabmaier U, Schöberl F, et al.
Journal article
Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms (2024)
Winter S, Schneider M, Oelschlaegel U, Maggioni G, Riva E, Raddi MG, Bencini S, et al.
Journal article
Checkpoint inhibitor-induced bullous pemphigoid differs from spontaneous bullous pemphigoid (2024)
Kramer N, Müller G, Zierold S, Röckel M, Fröhlich W, Schefzyk M, Kumbrink J, et al.
Journal article, Letter
Employing Graph Representations for Cell-Level Characterization of Melanoma MELC Samples (2023)
Rivera Monroy LC, Rist L, Eberhardt M, Ostalecki C, Baur A, Vera J, Breininger K, Maier A
Conference contribution
Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy (2023)
Reimann H, Kremer A, Blumenberg V, Schmidt K, Aigner M, Jacobs B, Eisenhauer N, et al.
Journal article, Letter
Is tebentafusp superior to combined immune checkpoint blockade and other systemic treatments in metastatic uveal melanoma? A comparative efficacy analysis with population adjustment (2023)
Petzold A, Steeb T, Wessely A, Koch E, Vera J, Berking C, Heppt M
Journal article, Review article
Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression. (2023)
Singh N, Khan FM, Bala L, Vera J, Wolkenhauer O, Pützer B, Logotheti S, Gupta SK
Journal article
Identifying biomarkers and novel therapeutic targets in uveal melanoma (2023)
Wessely A, Koch E, Vera J, Berking C, Heppt M
Journal article
Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections (2023)
Schmitt C, Hoefsmit EP, Fangmeier T, Kramer N, Kabakci C, Vera González J, Versluis JM, et al.
Journal article
Integration of transcriptomics data into agent-based models of solid tumor metastasis (2023)
Retzlaff J, Lai X, Berking C, Vera J
Journal article
‹
1
2
3
4
...
13
›